Rhodes Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for RHODES PHARMS
RHODES PHARMS has twenty-nine approved drugs.
There are two tentative approvals on RHODES PHARMS drugs.
Summary for Rhodes Pharms
| US Patents: | 0 |
| Tradenames: | 21 |
| Ingredients: | 19 |
| NDAs: | 29 |
Drugs and US Patents for Rhodes Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rhodes Pharms | OXYCODONE AND ACETAMINOPHEN | acetaminophen; oxycodone hydrochloride | TABLET;ORAL | 201278-002 | Aug 28, 2014 | AA | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Rhodes Pharms | MORPHINE SULFATE | morphine sulfate | TABLET, EXTENDED RELEASE;ORAL | 074862-002 | Jul 7, 1998 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Rhodes Pharms | DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE | amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate | CAPSULE, EXTENDED RELEASE;ORAL | 210651-003 | May 17, 2019 | AB1 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Rhodes Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Rhodes Pharms | APTENSIO XR | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 205831-001 | Apr 17, 2015 | 10,463,624 | ⤷ Start Trial |
| Rhodes Pharms | DILAUDID | hydromorphone hydrochloride | SOLUTION;ORAL | 019891-001 | Dec 7, 1992 | 6,589,960 | ⤷ Start Trial |
| Rhodes Pharms | DILAUDID | hydromorphone hydrochloride | TABLET;ORAL | 019892-003 | Nov 9, 2007 | 6,589,960 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for RHODES PHARMS drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Extended-release Capsules | 60 mg | ➤ Subscribe | 2015-12-23 |
| ➤ Subscribe | Extended-release Capsules | 15 mg, 20 mg, 40 mg and 50 mg | ➤ Subscribe | 2015-12-28 |
| ➤ Subscribe | Oral Solution | 5 mg/5mL | ➤ Subscribe | 2011-02-25 |
| ➤ Subscribe | Tablets | 2 mg, 4 mg, and 8 mg | ➤ Subscribe | 2013-08-05 |
| ➤ Subscribe | Extended-release Capsules | 10 mg | ➤ Subscribe | 2015-12-24 |
| ➤ Subscribe | Extended-release Capsules | 30 mg | ➤ Subscribe | 2016-03-28 |
| ➤ Subscribe | Injection | 2 mg/mL | ➤ Subscribe | 2011-06-22 |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
